Abstract
An informed consent discussion for a patient with Hypoactive Sexual Desire Disorder.
DOI
10.22237/crp/1622161200
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
YAEKLE S, ALI H, BAKER C. Informed Consent: There is insufficient evidence to recommend bremelanotide for hypoactive sexual desire disorder. Clin. Res. Prac. Aug 23 2021;7(1):eP2862. doi: 10.22237/crp/1622161200
Included in
Endocrinology, Diabetes, and Metabolism Commons, Family Medicine Commons, Medical Pharmacology Commons, Obstetrics and Gynecology Commons
